0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global POCT Molecular Diagnostics Technology Market Research Report 2026
Published Date: 2026-04-24
|
Report Code: QYRE-Auto-32U14218
Home | Market Reports | Science
Global POCT Molecular Diagnostics Technology Market Research Report 2023
BUY CHAPTERS

Global POCT Molecular Diagnostics Technology Market Research Report 2026

Code: QYRE-Auto-32U14218
Report
2026-04-24
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

POCT Molecular Diagnostics Technology Market Size

The global POCT Molecular Diagnostics Technology market was valued at US$ 6339 million in 2025 and is anticipated to reach US$ 11960 million by 2032, at a CAGR of 9.6% from 2026 to 2032.

POCT Molecular Diagnostics Technology Market

POCT Molecular Diagnostics Technology Market

Molecular POCT refers to a molecular biology detection system that is fully automated and integrated through technological innovation and optimization to meet the requirements of point-of-care testing (POCT). This system is an integrated closed system, and its nucleic acid extraction and amplification detection are all completed on the same closed, portable instrument, without the need for manual preparation of reagents or manual sample processing. No other manual operations are required from the time the sample is loaded on the machine to the result report, which can effectively prevent biological samples and their genetic materials from polluting the environment. It also has the characteristics of miniaturization, easy to carry, automation, full closure, fast speed, and easy operation. At the same time, it can ensure the high specificity and sensitivity of the detection performance, making it suitable for a variety of inspection scenarios such as hospital emergency, primary medical units, families, customs, and sudden disaster sites.
The growth of the molecular POCT (point-of-care testing) diagnostics market is driven by a number of drivers. First, the global prevalence of infectious diseases and the growing problem of antibiotic resistance have increased the demand for rapid and accurate molecular diagnostics. Molecular POCT can quickly detect pathogens on site and provide reliable results, reducing waiting time and helping medical staff to be more efficient in infection control and treatment decisions. In addition, technological advances have improved the convenience and detection range of molecular POCT systems, promoting their widespread use in primary care institutions, emergency rooms and telemedicine to meet the needs of decentralized medical care.
However, the molecular POCT market still faces some limiting factors. High costs and technical complexity are barriers to promotion in many regions, especially in resource-poor developing markets. In addition, although molecular POCT can provide results quickly, its accuracy may not be as good as laboratory testing in complex pathological conditions, limiting its application in certain high-precision demand environments. Strict regulatory requirements are also a major challenge. The complex approval process for medical devices in various countries may extend the time to market and affect the expansion speed of the market.
In terms of international market share and ranking, the main manufacturers are Danaher (Cepe), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher, Bio-Tech, Bio-Bio, Shengxiang Bio, Cayoudi, Hangzhou Ustar, etc. In 2023, the top five manufacturers accounted for about 94% of the international market.
Molecular POCT (Point-of-Care Testing) diagnosis is showing a rapid growth trend in the global medical market. With the outbreak of the new crown epidemic, the demand for molecular POCT has been unprecedentedly promoted. Molecular POCT technology enables disease detection to shift from traditional laboratory processes to immediate and convenient on-site testing, reducing the waiting time for testing and improving diagnostic efficiency. The increasing popularity of portable and rapid molecular testing equipment in primary care and remote areas has enabled high-precision molecular testing to be performed in places with insufficient medical resources. The development of such products has made the detection of infectious diseases (such as influenza, tuberculosis, sexually transmitted diseases, etc.) more convenient and improved public health.
As the molecular POCT market continues to expand, technological innovation is also accelerating. The application of emerging technologies such as nanomaterials, microfluidics, and CRISPR has promoted the miniaturization of molecular POCT devices and improved detection sensitivity, making the test results more accurate and faster. In addition, with the application of AI and the Internet of Things, the data management and analysis capabilities of molecular POCT devices have also been significantly enhanced, enabling them to be combined with telemedicine and cloud data sharing to bring more intelligent medical solutions. These technological advances have promoted the global application of molecular POCT, thereby improving the efficiency of disease prevention and public health management.
This report delivers a comprehensive overview of the global POCT Molecular Diagnostics Technology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding POCT Molecular Diagnostics Technology. The POCT Molecular Diagnostics Technology market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global POCT Molecular Diagnostics Technology market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist POCT Molecular Diagnostics Technology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of POCT Molecular Diagnostics Technology Market Report

Report Metric Details
Report Name POCT Molecular Diagnostics Technology Market
Accounted market size in 2025 US$ 6339 million
Forecasted market size in 2032 US$ 11960 million
CAGR 9.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Reagents Consumables
  • Equipment
  • Other
Segment by Application
  • Hospital
  • Decentralized Laboratory
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Danaher (Cepheid), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bohui Innovation, AoBio, Shengxiang Bio, Kayoudi, Hangzhou Yousda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for POCT Molecular Diagnostics Technology companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is POCT Molecular Diagnostics Technology Market growing?

Ans: The POCT Molecular Diagnostics Technology Market witnessing a CAGR of 9.6% during the forecast period 2026-2032.

What is the POCT Molecular Diagnostics Technology Market size in 2032?

Ans: The POCT Molecular Diagnostics Technology Market size in 2032 will be US$ 11960 million.

What is the market share of major companies in POCT Molecular Diagnostics Technology Market?

Ans: In 2023, the top five manufacturers accounted for about 94% of the international market.

Who are the main players in the POCT Molecular Diagnostics Technology Market report?

Ans: The main players in the POCT Molecular Diagnostics Technology Market are Danaher (Cepheid), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bohui Innovation, AoBio, Shengxiang Bio, Kayoudi, Hangzhou Yousda

What are the Application segmentation covered in the POCT Molecular Diagnostics Technology Market report?

Ans: The Applications covered in the POCT Molecular Diagnostics Technology Market report are Hospital, Decentralized Laboratory, Other

What are the Type segmentation covered in the POCT Molecular Diagnostics Technology Market report?

Ans: The Types covered in the POCT Molecular Diagnostics Technology Market report are Reagents Consumables, Equipment, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POCT Molecular Diagnostics Technology Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Reagents Consumables
1.2.3 Equipment
1.2.4 Other
1.3 Market by Application
1.3.1 Global POCT Molecular Diagnostics Technology Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Decentralized Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global POCT Molecular Diagnostics Technology Market Perspective (2021–2032)
2.2 Global POCT Molecular Diagnostics Technology Growth Trends by Region
2.2.1 Global POCT Molecular Diagnostics Technology Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 POCT Molecular Diagnostics Technology Historic Market Size by Region (2021–2026)
2.2.3 POCT Molecular Diagnostics Technology Forecasted Market Size by Region (2027–2032)
2.3 POCT Molecular Diagnostics Technology Market Dynamics
2.3.1 POCT Molecular Diagnostics Technology Industry Trends
2.3.2 POCT Molecular Diagnostics Technology Market Drivers
2.3.3 POCT Molecular Diagnostics Technology Market Challenges
2.3.4 POCT Molecular Diagnostics Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top POCT Molecular Diagnostics Technology Players by Revenue
3.1.1 Global Top POCT Molecular Diagnostics Technology Players by Revenue (2021–2026)
3.1.2 Global POCT Molecular Diagnostics Technology Revenue Market Share by Players (2021–2026)
3.2 Global Top POCT Molecular Diagnostics Technology Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by POCT Molecular Diagnostics Technology Revenue
3.4 Global POCT Molecular Diagnostics Technology Market Concentration Ratio
3.4.1 Global POCT Molecular Diagnostics Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POCT Molecular Diagnostics Technology Revenue in 2025
3.5 Global Key Players of POCT Molecular Diagnostics Technology Head Offices and Areas Served
3.6 Global Key Players of POCT Molecular Diagnostics Technology, Products and Applications
3.7 Global Key Players of POCT Molecular Diagnostics Technology, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 POCT Molecular Diagnostics Technology Breakdown Data by Type
4.1 Global POCT Molecular Diagnostics Technology Historic Market Size by Type (2021–2026)
4.2 Global POCT Molecular Diagnostics Technology Forecasted Market Size by Type (2027–2032)
5 POCT Molecular Diagnostics Technology Breakdown Data by Application
5.1 Global POCT Molecular Diagnostics Technology Historic Market Size by Application (2021–2026)
5.2 Global POCT Molecular Diagnostics Technology Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America POCT Molecular Diagnostics Technology Market Size (2021–2032)
6.2 North America POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America POCT Molecular Diagnostics Technology Market Size by Country (2021–2026)
6.4 North America POCT Molecular Diagnostics Technology Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe POCT Molecular Diagnostics Technology Market Size (2021–2032)
7.2 Europe POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe POCT Molecular Diagnostics Technology Market Size by Country (2021–2026)
7.4 Europe POCT Molecular Diagnostics Technology Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific POCT Molecular Diagnostics Technology Market Size (2021–2032)
8.2 Asia-Pacific POCT Molecular Diagnostics Technology Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2021–2026)
8.4 Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America POCT Molecular Diagnostics Technology Market Size (2021–2032)
9.2 Latin America POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America POCT Molecular Diagnostics Technology Market Size by Country (2021–2026)
9.4 Latin America POCT Molecular Diagnostics Technology Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa POCT Molecular Diagnostics Technology Market Size (2021–2032)
10.2 Middle East & Africa POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2021–2026)
10.4 Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher (Cepheid)
11.1.1 Danaher (Cepheid) Company Details
11.1.2 Danaher (Cepheid) Business Overview
11.1.3 Danaher (Cepheid) POCT Molecular Diagnostics Technology Introduction
11.1.4 Danaher (Cepheid) Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.1.5 Danaher (Cepheid) Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche POCT Molecular Diagnostics Technology Introduction
11.2.4 Roche Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.2.5 Roche Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott POCT Molecular Diagnostics Technology Introduction
11.3.4 Abbott Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.3.5 Abbott Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux POCT Molecular Diagnostics Technology Introduction
11.4.4 bioMérieux Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.4.5 bioMérieux Recent Development
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic POCT Molecular Diagnostics Technology Introduction
11.5.4 Hologic Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.5.5 Hologic Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific POCT Molecular Diagnostics Technology Introduction
11.6.4 Thermo Fisher Scientific Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Bohui Innovation
11.7.1 Bohui Innovation Company Details
11.7.2 Bohui Innovation Business Overview
11.7.3 Bohui Innovation POCT Molecular Diagnostics Technology Introduction
11.7.4 Bohui Innovation Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.7.5 Bohui Innovation Recent Development
11.8 AoBio
11.8.1 AoBio Company Details
11.8.2 AoBio Business Overview
11.8.3 AoBio POCT Molecular Diagnostics Technology Introduction
11.8.4 AoBio Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.8.5 AoBio Recent Development
11.9 Shengxiang Bio
11.9.1 Shengxiang Bio Company Details
11.9.2 Shengxiang Bio Business Overview
11.9.3 Shengxiang Bio POCT Molecular Diagnostics Technology Introduction
11.9.4 Shengxiang Bio Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.9.5 Shengxiang Bio Recent Development
11.10 Kayoudi
11.10.1 Kayoudi Company Details
11.10.2 Kayoudi Business Overview
11.10.3 Kayoudi POCT Molecular Diagnostics Technology Introduction
11.10.4 Kayoudi Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.10.5 Kayoudi Recent Development
11.11 Hangzhou Yousda
11.11.1 Hangzhou Yousda Company Details
11.11.2 Hangzhou Yousda Business Overview
11.11.3 Hangzhou Yousda POCT Molecular Diagnostics Technology Introduction
11.11.4 Hangzhou Yousda Revenue in POCT Molecular Diagnostics Technology Business (2021–2026)
11.11.5 Hangzhou Yousda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global POCT Molecular Diagnostics Technology Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Reagents Consumables
 Table 3. Key Players of Equipment
 Table 4. Key Players of Other
 Table 5. Global POCT Molecular Diagnostics Technology Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global POCT Molecular Diagnostics Technology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global POCT Molecular Diagnostics Technology Market Size by Region (US$ Million), 2021–2026
 Table 8. Global POCT Molecular Diagnostics Technology Market Share by Region (2021–2026)
 Table 9. Global POCT Molecular Diagnostics Technology Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global POCT Molecular Diagnostics Technology Market Share by Region (2027–2032)
 Table 11. POCT Molecular Diagnostics Technology Market Trends
 Table 12. POCT Molecular Diagnostics Technology Market Drivers
 Table 13. POCT Molecular Diagnostics Technology Market Challenges
 Table 14. POCT Molecular Diagnostics Technology Market Restraints
 Table 15. Global POCT Molecular Diagnostics Technology Revenue by Players (US$ Million), 2021–2026
 Table 16. Global POCT Molecular Diagnostics Technology Market Share by Players (2021–2026)
 Table 17. Global Top POCT Molecular Diagnostics Technology Players by Tier (Tier 1, Tier 2, and Tier 3), based on POCT Molecular Diagnostics Technology Revenue, 2025
 Table 18. Ranking of Global Top POCT Molecular Diagnostics Technology Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by POCT Molecular Diagnostics Technology Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of POCT Molecular Diagnostics Technology, Headquarters and Area Served
 Table 21. Global Key Players of POCT Molecular Diagnostics Technology, Products and Applications
 Table 22. Global Key Players of POCT Molecular Diagnostics Technology, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global POCT Molecular Diagnostics Technology Market Size by Type (US$ Million), 2021–2026
 Table 25. Global POCT Molecular Diagnostics Technology Revenue Market Share by Type (2021–2026)
 Table 26. Global POCT Molecular Diagnostics Technology Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global POCT Molecular Diagnostics Technology Revenue Market Share by Type (2027–2032)
 Table 28. Global POCT Molecular Diagnostics Technology Market Size by Application (US$ Million), 2021–2026
 Table 29. Global POCT Molecular Diagnostics Technology Revenue Market Share by Application (2021–2026)
 Table 30. Global POCT Molecular Diagnostics Technology Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global POCT Molecular Diagnostics Technology Revenue Market Share by Application (2027–2032)
 Table 32. North America POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America POCT Molecular Diagnostics Technology Market Size by Country (US$ Million), 2021–2026
 Table 34. North America POCT Molecular Diagnostics Technology Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe POCT Molecular Diagnostics Technology Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe POCT Molecular Diagnostics Technology Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific POCT Molecular Diagnostics Technology Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America POCT Molecular Diagnostics Technology Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America POCT Molecular Diagnostics Technology Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (US$ Million), 2027–2032
 Table 47. Danaher (Cepheid) Company Details
 Table 48. Danaher (Cepheid) Business Overview
 Table 49. Danaher (Cepheid) POCT Molecular Diagnostics Technology Product
 Table 50. Danaher (Cepheid) Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 51. Danaher (Cepheid) Recent Development
 Table 52. Roche Company Details
 Table 53. Roche Business Overview
 Table 54. Roche POCT Molecular Diagnostics Technology Product
 Table 55. Roche Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 56. Roche Recent Development
 Table 57. Abbott Company Details
 Table 58. Abbott Business Overview
 Table 59. Abbott POCT Molecular Diagnostics Technology Product
 Table 60. Abbott Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 61. Abbott Recent Development
 Table 62. bioMérieux Company Details
 Table 63. bioMérieux Business Overview
 Table 64. bioMérieux POCT Molecular Diagnostics Technology Product
 Table 65. bioMérieux Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 66. bioMérieux Recent Development
 Table 67. Hologic Company Details
 Table 68. Hologic Business Overview
 Table 69. Hologic POCT Molecular Diagnostics Technology Product
 Table 70. Hologic Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 71. Hologic Recent Development
 Table 72. Thermo Fisher Scientific Company Details
 Table 73. Thermo Fisher Scientific Business Overview
 Table 74. Thermo Fisher Scientific POCT Molecular Diagnostics Technology Product
 Table 75. Thermo Fisher Scientific Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 76. Thermo Fisher Scientific Recent Development
 Table 77. Bohui Innovation Company Details
 Table 78. Bohui Innovation Business Overview
 Table 79. Bohui Innovation POCT Molecular Diagnostics Technology Product
 Table 80. Bohui Innovation Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 81. Bohui Innovation Recent Development
 Table 82. AoBio Company Details
 Table 83. AoBio Business Overview
 Table 84. AoBio POCT Molecular Diagnostics Technology Product
 Table 85. AoBio Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 86. AoBio Recent Development
 Table 87. Shengxiang Bio Company Details
 Table 88. Shengxiang Bio Business Overview
 Table 89. Shengxiang Bio POCT Molecular Diagnostics Technology Product
 Table 90. Shengxiang Bio Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 91. Shengxiang Bio Recent Development
 Table 92. Kayoudi Company Details
 Table 93. Kayoudi Business Overview
 Table 94. Kayoudi POCT Molecular Diagnostics Technology Product
 Table 95. Kayoudi Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 96. Kayoudi Recent Development
 Table 97. Hangzhou Yousda Company Details
 Table 98. Hangzhou Yousda Business Overview
 Table 99. Hangzhou Yousda POCT Molecular Diagnostics Technology Product
 Table 100. Hangzhou Yousda Revenue in POCT Molecular Diagnostics Technology Business (US$ Million), 2021–2026
 Table 101. Hangzhou Yousda Recent Development
 Table 102. Research Programs/Design for This Report
 Table 103. Key Data Information from Secondary Sources
 Table 104. Key Data Information from Primary Sources
 Table 105. Authors List of This Report


List of Figures
 Figure 1. POCT Molecular Diagnostics Technology Picture
 Figure 2. Global POCT Molecular Diagnostics Technology Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global POCT Molecular Diagnostics Technology Market Share by Type: 2025 vs 2032
 Figure 4. Reagents Consumables Features
 Figure 5. Equipment Features
 Figure 6. Other Features
 Figure 7. Global POCT Molecular Diagnostics Technology Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global POCT Molecular Diagnostics Technology Market Share by Application: 2025 vs 2032
 Figure 9. Hospital Case Studies
 Figure 10. Decentralized Laboratory Case Studies
 Figure 11. Other Case Studies
 Figure 12. POCT Molecular Diagnostics Technology Report Years Considered
 Figure 13. Global POCT Molecular Diagnostics Technology Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global POCT Molecular Diagnostics Technology Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global POCT Molecular Diagnostics Technology Market Share by Region: 2025 vs 2032
 Figure 16. Global POCT Molecular Diagnostics Technology Market Share by Players in 2025
 Figure 17. Global POCT Molecular Diagnostics Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by POCT Molecular Diagnostics Technology Revenue in 2025
 Figure 19. North America POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America POCT Molecular Diagnostics Technology Market Share by Country (2021–2032)
 Figure 21. United States POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe POCT Molecular Diagnostics Technology Market Share by Country (2021–2032)
 Figure 25. Germany POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific POCT Molecular Diagnostics Technology Market Share by Region (2021–2032)
 Figure 33. China POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America POCT Molecular Diagnostics Technology Market Share by Country (2021–2032)
 Figure 41. Mexico POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa POCT Molecular Diagnostics Technology Market Share by Country (2021–2032)
 Figure 45. Israel POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE POCT Molecular Diagnostics Technology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Danaher (Cepheid) Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 49. Roche Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 50. Abbott Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 51. bioMérieux Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 52. Hologic Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 53. Thermo Fisher Scientific Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 54. Bohui Innovation Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 55. AoBio Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 56. Shengxiang Bio Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 57. Kayoudi Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 58. Hangzhou Yousda Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2021–2026)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc